Common Contracts
2 similar null contracts by Achieve Life Sciences, Inc.
ACHIEVE LIFE SCIENCES, INC. UNDERWRITING AGREEMENTAchieve Life Sciences, Inc. • December 16th, 2019 • In vitro & in vivo diagnostic substances • New York
any member of the immediate family (as defined below) of the undersigned or to a trust the beneficiaries of which are exclusively the undersigned or members of the undersigned’s immediate family, (b) by will or intestate succession upon the death of the undersigned, or (c) as a bona fide gift to a charity or educational institution, provided, however, that (A) it shall be a condition to the transfer that the transferee executes and delivers to the Representatives written agreement, in substantially the form of this Agreement (it being understood that any references to “immediate family” in the agreement executed by such transferee shall expressly refer only to the immediate family of the undersigned and not to the immediate family of the transferee), and (B) if the undersigned is required to file a report under Section 16(a) of the Exchange Act, reporting a reduction in beneficial ownership of Securities during the Restriction Period, the undersigned shall include a statement in such r
ACHIEVE LIFE SCIENCES, INC. UNDERWRITING AGREEMENTAchieve Life Sciences, Inc. • December 2nd, 2019 • In vitro & in vivo diagnostic substances • New York
any member of the immediate family (as defined below) of the undersigned or to a trust the beneficiaries of which are exclusively the undersigned or members of the undersigned’s immediate family, (b) by will or intestate succession upon the death of the undersigned, or (c) as a bona fide gift to a charity or educational institution, provided, however, that (A) it shall be a condition to the transfer that the transferee executes and delivers to the Representatives written agreement, in substantially the form of this Agreement (it being understood that any references to “immediate family” in the agreement executed by such transferee shall expressly refer only to the immediate family of the undersigned and not to the immediate family of the transferee), and (B) if the undersigned is required to file a report under Section 16(a) of the Exchange Act, reporting a reduction in beneficial ownership of Securities during the Restriction Period, the undersigned shall include a statement in such r
